Rafferty Asset Management’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-215,729
| Closed | -$997K | – | 1142 |
|
|
2023
Q1 | $997K | Buy |
215,729
+117,092
| +119% | +$541K | 0.01% | 800 |
|
|
2022
Q4 | $797K | Buy |
+98,637
| New | +$797K | 0.01% | 807 |
|
|
2022
Q2 | – | Sell |
-164,790
| Closed | -$1.36M | – | 1220 |
|
|
2022
Q1 | $1.36M | Buy |
164,790
+83,661
| +103% | +$688K | 0.01% | 714 |
|
|
2021
Q4 | $1.21M | Buy |
81,129
+25,420
| +46% | +$378K | 0.01% | 797 |
|
|
2021
Q3 | $1.05M | Sell |
55,709
-32,460
| -37% | -$613K | 0.01% | 802 |
|
|
2021
Q2 | $1.64M | Sell |
88,169
-49,134
| -36% | -$913K | 0.01% | 740 |
|
|
2021
Q1 | $3.13M | Buy |
+137,303
| New | +$3.13M | 0.02% | 460 |
|